Patient Buzz: Microdosing Isotretinoin | The Expert Weighs In
Vogue wrote an article about the ‘Hollywood Dose’ – microdosing isotretinoin for clearer skin. The concept of a reduced dose was once popular among models and actors who were looking for a flawless, glowing look. Yet dermatologists say prescribing isotretinoin at levels lower than the traditional dose can be beneficial for some everyday acne patients, too. Low-dose isotretinoin offers fewer …
Vogue wrote an article about the ‘Hollywood Dose’ – microdosing isotretinoin for clearer skin. The concept of a reduced dose was once popular among models and actors who were looking for a flawless, glowing look. Yet dermatologists say prescribing isotretinoin at levels lower than the traditional dose can be beneficial for some everyday acne patients, too. Low-dose isotretinoin offers fewer … Continue reading "Patient Buzz: Microdosing Isotretinoin | The Expert Weighs In"
The burden of vitiligo is significant in patients with skin of color, which makes treatment breakthroughs more impactful. Dr. Pearl E. Grimes, chair of the Pigmentary Disorders Exchange Symposium, spoke with Next Steps in Derm, in partnership with Skin of Color Update, about breakthroughs in the treatment of vitiligo in patients with skin of color. Find out which therapies have enhanced results i … 
What is the underlying gene defect for this transgrediens form of palmoplanter keratoderma?
A. SLURP-1
B. TOC gene
C. Plakoglobin
D. Keratin type 1
E. Keratin type 9
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers. … 
Transitioning from residency to your first dermatology position is one of the most exciting and intimidating steps in your career. The job you choose (and the contract you sign) will shape not only your salary but also your professional development, work-life balance, and long-term satisfaction. It is crucial to learn how to evaluate job benefits before you sit down at the negotiating table to avo … 
GLP-1 receptor agonists are revolutionizing the treatment of type 2 diabetes and obesity. With widespread consumer advertising campaigns, GLP-1 usage is becoming commonplace. National polls show up to one-fifth of American adults have tried GLP-1s for weight loss or to address health conditions, such as heart disease. As the understanding of GLP-1s deepens, so does their potential. Since recent re …